Menu Search
Equities

Medimi AB

79T:FRA

Medimi AB

Actions
  • Price (EUR)0.0002
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-91.03%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:02 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Medimi AB grew revenues 75.13% from 2.08m to 3.64m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -15.41m to -14.25m.
Gross margin40.84%
Net profit margin-326.40%
Operating margin-319.46%
Return on assets-101.01%
Return on equity-152.37%
Return on investment-126.70%
More ▼

Cash flow in SEKView more

In 2023, Medimi AB increased its cash reserves by 15.58%, or 1.66m. Cash Flow from Financing totalled 15.75m or 432.85% of revenues. In addition the company used 12.66m for operations while cash used for investing totalled 1.43m.
Cash flow per share-0.0139
Price/Cash flow per share--
Book value per share0.0072
Tangible book value per share0.0072
More ▼

Balance sheet in SEKView more

Medimi AB appears to have little financial risk as the company holds a substantial amount of cash on its books. In fact, 1.73% of the market capitalization can be attributed to its 12.31m and debt could be paid in full if management chose.
Current ratio3.40
Quick ratio2.52
Total debt/total equity0.387
Total debt/total capital0.279
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.